Moderately hyperglycemia as an independent prognostic factor for the worse outcome of COVID-19

Blood sugar (BS) has been proposed as a prognostic factor for COVID-19. In this historical cohort study we evaluated the association between admission time BS and COVID-19 outcome. First, hospitalized COVID-19 patients were divided into three groups; Non-diabetic patients with BS

Saved in:
Bibliographic Details
Published in:Primary care diabetes 2022-06, Vol.16 (3), p.361-364
Main Authors: Nateghi, Saeed, Gomari, Mohammad Mahmoudi, roudsari, Yousef Jalali, Foroughi, Alireza, Mansouri, Fariba, Shiva, Ashkan, Nasrollahizadeh, Ali, Nasiri, Zohreh, Faraji, Neda
Format: Article
Language:English
Subjects:
Blood Glucose
Blood Sugar
Cohort Studies
COVID-19
Diabetes
Diabetes Mellitus - diagnosis
Diabetes Mellitus - epidemiology
Diabetes Mellitus - therapy
Humans
Hyperglycemia
Hyperglycemia - diagnosis
Hyperglycemia - epidemiology
Mortality
Prognosis
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Blood sugar (BS) has been proposed as a prognostic factor for COVID-19. In this historical cohort study we evaluated the association between admission time BS and COVID-19 outcome. First, hospitalized COVID-19 patients were divided into three groups; Non-diabetic patients with BS
ISSN:1751-9918
1878-0210
DOI:10.1016/j.pcd.2022.03.005